시장보고서
상품코드
1555495

연속 바이오프로세싱 시장 : 제품별, 운영규모별, 공정별, 용도별, 최종사용자별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 및 예측(2024-2032년)

Continuous Bioprocessing Market, By Product, By Scale of Operation, By Process, By Application, By End-user, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 380 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

연속 바이오프로세싱 시장 규모는 2023년 2억 1,460만 달러로 평가되었고, 2024-2032년간 연평균 복합 성장률(CAGR) 21.40%로 확대될 것으로 예상됩니다.

연속 바이오프로세싱 시장 - 시장 역학

바이오 의약품 수요 증가로 시장 성장 촉진

바이오의약품은 높은 활성과 선택성, 적은 부작용, 특정 분자를 표적으로 삼을 수 있는 능력으로 인해 수요가 증가하고 있습니다. 암, 염증성 장질환(IBD), 류마티스 관절염(RA)과 같은 면역 매개 염증성 질환(IMID)의 치료는 점점 더 바이오 의약품에 의존하고 있습니다. 이러한 꾸준한 증가는 바이오 의약품 승인 시장의 확대에도 영향을 미치고 있습니다. 미국 FDA의 보고에 따르면, 2022년 승인될 의약품 중 15개 품목이 바이오의약품으로 2020년 13개 품목에 비해 크게 증가했습니다. 또한 상업 생산에 연속 생산 기술을 도입하면 생산 비용이 낮아집니다. 생산성이 향상됨에 따라 바이오 의약품의 비용이 낮아지고 의약품에 대한 접근이 용이해져 표준 치료가 향상됩니다. 바이오 의약품 제조는 연속 바이오프로세싱에 의해 변화하고 있습니다. 연속 바이오프로세싱은 전통적인 흐름 제조에 비해 장점이 많기 때문에 바이오 의약품 제조에 널리 사용되고 있습니다. 이러한 장점에는 공정 설계의 유연성 향상, 공정 경제성 개선, 확장 용이성, 개발 기간 단축 등이 포함됩니다.

연속 바이오프로세싱 시장 - 주요 인사이트

당사의 리서치 애널리스트들의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 21.40%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

제품 세분화에 따라 여과 시스템 및 장치 카테고리는 2023년에 가장 높은 시장 점유율을 보였습니다.

운영 규모에 따라 2023년에는 상업 운영 부문이 주요 부문으로 부상했습니다.

용도별로는 2023년 단클론항체 카테고리가 주요 부문으로 꼽혔습니다.

최종 사용자별로는 제약 및 생명공학 기업이 2023년 주요 부문으로 꼽혔습니다.

지역별로는 북미가 2023년 주요 수익원이었습니다.

연속 바이오프로세싱 시장 - 세분화 분석 :

세계 연속 바이오프로세싱 시장은 제품, 운영 규모, 공정, 용도, 최종 사용자 및 지역별로 분류됩니다.

시장은 운영 규모에 따라 상업 운영과 임상 운영의 두 가지 범주로 나뉩니다. 상업적 운영 부문이 시장을 지배하고 있습니다. 백신, 세포 및 유전자 치료제, 단일 클론 항체, 기타 생물학적 제제 등 바이오 의약품에 대한 강력한 수요가 상업적 부문을 뒷받침하고 있습니다. 또한, 세계 인구의 고령화와 만성 질환의 유행으로 인해 첨단 바이오 의약품에 대한 수요가 증가하고 있으며, 이는 상업 부문의 확장을 더욱 촉진하고 있습니다. 또한, 연속 바이오프로세싱은 기존 배치 처리 기술과 비교하여 생산성 향상과 공정 제어 개선 등의 이점을 제공하므로 대규모 상업 생산에 적합합니다.

시장은 공정에 따라 다운스트림 바이오프로세스와 업스트림 바이오프로세스의 두 가지 범주로 나뉩니다. 다운스트림 바이오프로세스 카테고리가 시장을 독점하고 있으며, 예측 기간 동안 그 우위를 유지할 것으로 보입니다. 이 분야의 부상은 규제 기준을 충족하고, 제품 품질을 달성하고, 바이오 의약품의 가치를 크게 높이는 데 중요한 기능을 수행하기 때문입니다. 또한, 제조업체들은 아웃소싱 추세와 생물학적 제제에 대한 수요 증가에 따라 제품의 품질과 안전성을 보장하기 위해 견고하고 효율적인 정제 공정을 우선순위에 두고 있으며, 이는 이 분야의 성장을 가속하고 있습니다. 또한, 바이오제약 기업들은 공정의 생산성, 효율성 및 확장성을 향상시킴으로써 다운스트림 처리 솔루션의 기술 혁신을 통해 이 분야 시장 성장을 더욱 촉진할 수 있습니다.

연속적인 바이오프로세스 시장 - 지리적 통찰력

지역적으로 이 시장은 북미, 중남미, 유럽, 아시아태평양, 중동 및 아프리카에 걸쳐 있습니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다.

예측 기간 동안 북미는 연속 바이오프로세싱 세계 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 유명 제약회사를 포함한 수많은 바이오 제약회사가 북미에 본사를 두고 있습니다. 이들 기업은 생물학적 제제 개발 및 판매의 선구자이며, 생산 공정을 최적화하고 생산량을 개선하며 제품 품질을 보장하기 위해 지속적인 바이오프로세스 기술의 필요성을 촉진하고 있습니다. 또한, 이 지역은 바이오 가공 기술의 발전을 지원하는 학술 기관, 연구시설 및 생명공학 허브의 강력한 네트워크를 자랑합니다.

또한, 연속 바이오프로세싱 시장은 바이오 제약 부문의 성장, 생명과학 연구 증가, 생명공학 및 제약 기업의 투자 증가,(CMO) 시장 확대 등의 요인으로 인해 아시아태평양에서 예측 기간 동안 세계에서 가장 빠른 속도로 성장할 것으로 예상됩니다. 아시아태평양의 기업과 연구기관들은 최첨단 바이오프로세스 플랫폼을 구축하기 위해 많은 연구개발 투자를 하고 있으며, 이는 지속적인 바이오프로세스 개선을 촉진하고 세계 시장에서 경쟁력을 유지하는 데 도움이 되고 있습니다.

연속 바이오프로세싱 시장 - 경쟁 환경:

다이나믹하고 변화무쌍한 연속 바이오프로세싱 분야에는 Merck KGaA, Sartorius AG, Thermo Fisher Scientific 등 다양한 유형의 기업이 존재합니다. 기술 발전과 바이오 의약품에 대한 수요 증가로 인해 기술 혁신과 시장 통합이 더욱 가속화되고 시장 경쟁은 더욱 치열해질 것으로 예상됩니다.

목차

제1장 연속 바이오프로세싱 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 연속 바이오프로세싱 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 향후 동향

제4장 연속 바이오프로세싱 산업 연구

  • PEST 분석
  • Porter의 Five Forces 분석
  • 성장 전망 매핑
  • 규제 구조 분석

제5장 연속 바이오프로세싱 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 연속 바이오프로세싱 시장 구도

  • 연속 바이오프로세싱 시장 점유율 분석, 2023년
  • 분석 데이터 : 주요 제조업체별
    • 기존 기업 분석
    • 신규 기업 분석

제7장 연속 바이오프로세싱 시장 : 제품별

  • 개요
    • 부문 점유율 분석 : 제품별
    • 크로마토그래피 시스템 및 소모품
    • 여과 시스템 및 장비
    • 바이오리액터
    • 세포배양 배지, 세포주, 완충액, 시약
    • 기타 제품

제8장 연속 바이오프로세싱 시장 : 운영 규모별

  • 개요
    • 부문 점유율 분석 : 운영 규모별
    • 상업 운영
    • 임상 업무

제9장 연속 바이오프로세싱 시장 : 프로세스별

  • 개요
    • 부문 점유율 분석 : 프로세스별
    • Downstream 바이오프로세스
    • Upstream 바이오프로세스

제10장 연속 바이오프로세싱 시장 : 용도별

  • 개요
    • 부문 점유율 분석 : 용도별
    • 단클론항체
    • 백신
    • 세포 및 유전자 치료
    • 기타 용도

제11장 연속 바이오프로세싱 시장 : 최종사용자별

  • 개요
    • 부문 점유율 분석 : 최종사용자별
    • 제약 기업 및 바이오테크놀러지 기업
    • 계약연구기관 및 계약제조기관
    • 학술기관 및 연구기관

제12장 연속 바이오프로세싱 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제13장 주요 벤더 분석 - 연속 바이오프로세싱 산업

  • 경쟁 대시보드
  • 기업 개요
    • 3M Company
    • Bionet
    • FUJIFILM HOLDINGS CORPORATION
    • Merck KGaA
    • Repligen Corporation
    • Danaher Corporation(Pall Corporation)
    • Eppendorf SE
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Wuxi Biologics
    • 기타

제14장 애널리스트의 전방위 전망

LSH 24.10.18

REPORT HIGHLIGHT

Continuous Bioprocessing Market size was valued at USD 214.6 Million in 2023, expanding at a CAGR of 21.40% from 2024 to 2032.

The integrated continuous unit processes used in continuous bioprocessing do not have intermediary holding tanks; instead, the product flows continuously through them and into containers. Extremely intense processing with brief downtimes is a characteristic of continuous unit operations. A multi-column chromatography system, a perfusion bioreactor, and multi-column intermediate purification are components of an end-to-end bioprocess. For continuous biopharmaceutical manufacturing, some pharmaceutical and biopharmaceutical producers use a hybrid strategy where just the upstream or downstream process is continuous.

Continuous Bioprocessing Market- Market Dynamics

Increased Demand for Biopharmaceuticals to Propel Market Growth

Biopharmaceuticals are in greater demand because of their high activity and selectivity, low side effects, and capacity to target particular molecules. The treatment of immune-mediated inflammatory diseases (IMIDs), such as cancer, inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), is becoming more and more dependent on biopharmaceuticals. The steady rise also aids the market's expansion in biopharmaceutical approvals. The U.S. FDA reports that of all the medications authorized in 2022, 15 were biologics, as opposed to 13 in 2020. Additionally, implementing continuous manufacturing techniques in commercial production lowers manufacturing costs. It increases productivity, which lowers the cost of biopharmaceutical products, increases accessibility to medications, and enhances the standard of care. Biopharmaceutical manufacturing is changing as a result of continuous bioprocessing. Continuous bioprocessing is becoming more widely used in the production of biopharmaceuticals due to its advantages over traditional flow manufacturing. These advantages include enhanced process design flexibility, improved process economics, ease of scale-up, and quick development timelines.

Continuous Bioprocessing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.40% over the forecast period (2024-2032)

Based on product segmentation, the Filtration Systems and Devices category was predicted to show maximum market share in the year 2023

Based on the scale of operation segmentation, the commercial operations category was the leading segment in 2023

Based on application segmentation, the Monoclonal Antibodies category was the leading segment in 2023

Based on end-user segmentation, the Pharmaceutical and Biotechnology Companies category was the leading segment in 2023

Based on region, North America was the leading revenue generator in 2023

Continuous Bioprocessing Market- Segmentation Analysis:

The Global Continuous Bioprocessing Market is segmented based on Product, Scale of Operation, Process, Application, End-user and Region.

The market is divided into two categories based on scale of operation: Commercial Operations and Clinical Operations. The commercial operations category dominates the market. The strong demand for biopharmaceutical goods, such as vaccines, cell and gene therapies, monoclonal antibodies, and other biologics, helps the commercial sector. Additionally, the need for sophisticated biopharmaceutical medicines is expanding as the world's population ages and the prevalence of chronic diseases rises, which is propelling the commercial segment's expansion even further. Furthermore, compared to conventional batch processing techniques, continuous bioprocessing provides benefits like increased productivity and improved process control, which makes it a good fit for large-scale commercial production.

The market is divided into two categories based on Process: Downstream Bioprocess and Upstream Bioprocess. The downstream bioprocess category dominates the market and is likely to maintain its dominance during the forecast period. The segment's rise is ascribed to its vital function in fulfilling regulatory standards, achieving product quality, and significantly enhancing the value of biopharmaceutical goods. Additionally, manufacturers prioritize robust and efficient purification processes to ensure product quality and safety in light of growing outsourcing trends and the demand for biologics, which in turn enhances segmental growth. Moreover, ongoing innovations in downstream processing solutions allow biopharmaceutical companies to further drive market growth in this segment by improving process productivity, efficiency, and scalability.

Continuous Bioprocessing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Throughout the forecast period, North America is anticipated to hold the greatest share of the global market for Continuous Bioprocessing. Numerous biopharmaceutical businesses, including well-known pharmaceutical corporations, are based in North America. These businesses are pioneers in the creation and marketing of biologic medications, which fuels the need for ongoing bioprocessing technology to optimize production processes, boost output, and guarantee product quality. Furthermore, this area is proud of its strong network of academic institutions, research facilities, and biotechnology hubs that support the advancement of bioprocessing technology.

In addition, the Continuous Bioprocessing market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific driven by factors like the growth of the biopharmaceutical sector, a rise in life sciences research, an increase in investments made by biotechnology and pharmaceutical businesses, and the expanding market for (CMOs). Companies and research institutions in Asia Pacific make significant R&D investments to create state-of-the-art bioprocessing platforms that propel continual bioprocessing improvements and help them keep a competitive edge in the worldwide market.

Continuous Bioprocessing Market- Competitive Landscape:

There are many different types of players in the dynamic and varied continuous bioprocessing sector, including Merck KGaA, Sartorius AG, and Thermo Fisher Scientific. The market is predicted to become more competitive as technology develops and the need for biopharmaceuticals rises, spurring additional innovation and market consolidation.

Recent Developments:

August 2023: To improve upstream process intensification, Sartorius and Repligen Corporation unveiled an integrated bioreactor system that combined Biostat STR and XCell ATF technology. It is anticipated that the launch will assist the business in growing both its sales revenue and product portfolio.

March 2023: Curia and Corning worked together to establish and expedite continuous-flow manufacturing and development programs for the global chemical and biopharmaceutical sectors. Through this partnership, Corning's G1 production system-which supports the use of flow-chemistry technology to produce APIs of higher quality-will be installed for the first time in the world.

July 2022: Cytiva opened a new location in Muskegon, Michigan, to expand its business. The new manufacturing facility for chromatography resins is a component of Cytiva's investment in growth.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS BIOPROCESSING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M Company
  • Bionet
  • FUJIFILM HOLDINGS CORPORATION
  • Merck KGaA
  • Repligen Corporation
  • Danaher Corporation (Pall Corporation)
  • Eppendorf SE
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Wuxi Biologics
  • Others

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Chromatography Systems and Consumables
  • Filtration Systems and Devices
  • Bioreactors
  • Cell Culture Media, Cell Lines, Buffers and Reagents
  • Other Products

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY SCALE OF OPERATION- MARKET ANALYSIS, 2019 - 2032

  • Commercial Operations
  • Clinical Operations

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY PROCESS- MARKET ANALYSIS, 2019 - 2032

  • Downstream Bioprocess
  • Upstream Bioprocess

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies
  • Vaccines
  • Cell and Gene Therapy
  • Other Applications

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations and Contract Manufacturing Organizations
  • Academic and Research Institutes

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Continuous Bioprocessing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Continuous Bioprocessing Market Snippet by Product
    • 2.1.2. Continuous Bioprocessing Market Snippet by Scale of Operation
    • 2.1.3. Continuous Bioprocessing Market Snippet by Process
    • 2.1.4. Continuous Bioprocessing Market Snippet by Application
    • 2.1.5. Continuous Bioprocessing Market Snippet by End-user
    • 2.1.6. Continuous Bioprocessing Market Snippet by Country
    • 2.1.7. Continuous Bioprocessing Market Snippet by Region
  • 2.2. Competitive Insights

3. Continuous Bioprocessing Key Market Trends

  • 3.1. Continuous Bioprocessing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Continuous Bioprocessing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Continuous Bioprocessing Market Opportunities
  • 3.4. Continuous Bioprocessing Market Future Trends

4. Continuous Bioprocessing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Continuous Bioprocessing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Continuous Bioprocessing Market Landscape

  • 6.1. Continuous Bioprocessing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Continuous Bioprocessing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Chromatography Systems and Consumables
    • 7.1.3. Filtration Systems and Devices
    • 7.1.4. Bioreactors
    • 7.1.5. Cell Culture Media, Cell Lines, Buffers and Reagents
    • 7.1.6. Other Products

8. Continuous Bioprocessing Market - By Scale of Operation

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Scale of Operation, 2023 & 2032 (%)
    • 8.1.2. Commercial Operations
    • 8.1.3. Clinical Operations

9. Continuous Bioprocessing Market - By Process

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Process, 2023 & 2032 (%)
    • 9.1.2. Downstream Bioprocess
    • 9.1.3. Upstream Bioprocess

10. Continuous Bioprocessing Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Monoclonal Antibodies
    • 10.1.3. Vaccines
    • 10.1.4. Cell and Gene Therapy
    • 10.1.5. Other Applications

11. Continuous Bioprocessing Market - By End-user

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
    • 11.1.2. Pharmaceutical and Biotechnology Companies
    • 11.1.3. Contract Research Organizations and Contract Manufacturing Organizations
    • 11.1.4. Academic and Research Institutes

12. Continuous Bioprocessing Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Continuous Bioprocessing Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Continuous Bioprocessing Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Continuous Bioprocessing Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Continuous Bioprocessing Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Continuous Bioprocessing Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Continuous Bioprocessing Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. 3M Company
    • 13.2.2. Bionet
    • 13.2.3. FUJIFILM HOLDINGS CORPORATION
    • 13.2.4. Merck KGaA
    • 13.2.5. Repligen Corporation
    • 13.2.6. Danaher Corporation (Pall Corporation)
    • 13.2.7. Eppendorf SE
    • 13.2.8. Sartorius AG
    • 13.2.9. Thermo Fisher Scientific Inc.
    • 13.2.10. Wuxi Biologics
    • 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제